<DOC>
	<DOCNO>NCT01703650</DOCNO>
	<brief_summary>The purpose study 1. determine whether perfusion parameter normal pancreas pancreas cancer ( adenocarcinoma neuroendocrine tumor ) different perfusion CT 2. determine whether initial perfusion parameter well perfusion parameter change pancreas adenocarcinoma chemotherapy different chemotherapy response group ( CR , PR accord RECIST 1.1 ) non response group ( SD , PD accord RECIST 1.1 ) .</brief_summary>
	<brief_title>Role Perfusion CT Pancreatic Cancer</brief_title>
	<detailed_description>1 . Performance preoperative perfusion CT preoperative staging assess compare operative find histologic disease stag 2 . Estimation initial change pancreas cancer perfusion parameter whether provide cut-off value predict response chemotherapy patient pancreas adenocarcinoma</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Neuroendocrine</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>patient older eighteen year patient operation preoperative compute tomography schedule resectable pancreas adenocarcinoma pancreas neuroendocrine tumor patient chemotherapy schedule histologically confirm pancreas adenocarcinoma patient chemotherapy plan highly suspicious pancreas adenocarcinoma image workup patient agree study whose informed consent obtain . patient young eighteen year old patient previously radiation therapy perform RTx field include pancreas patient recur pancreas adenocarcinoma patient pregnant nursing patient patient renal failure ( GFR &lt; 30mL/min ) patient history malignancy , except malignancy complete remission operation iodine therapy least five year ) patient hypersensitivity iodine contrast medium cause contraindication contrastmedia enhance CT scan Any condition , opinion Investigator , would make patient unsuitable enrollment could interfere completion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>CT</keyword>
	<keyword>pancreas adenocarcinoma</keyword>
	<keyword>RECIST</keyword>
	<keyword>perfusion</keyword>
</DOC>